SIM
RGLS

Sonora Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Sonora Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1109
2021
Q2 		$0 Hold
2
– – ﹤0.01% 1054
2021
Q1 		$0 Hold
2
– – ﹤0.01% 1778
2020
Q4 		$0 Hold
2
– – ﹤0.01% 1760
2020
Q3 		$0 Hold
2
– – ﹤0.01% 1862
2020
Q2 		$0 Hold
2
– – ﹤0.01% 1855
2020
Q1 		$0 Hold
2
– – ﹤0.01% 1724
2019
Q4 		$0 Hold
2
– – ﹤0.01% 1720
2019
Q3 		$0 Hold
2
– – ﹤0.01% 1808
2019
Q2 		$0 Hold
2
– – ﹤0.01% 1725
2019
Q1 		$0 Hold
2
– – ﹤0.01% 1527
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1281
2018
Q3 		$0 Hold
2
– – ﹤0.01% 1249
2018
Q2 		$0 Hold
2
– – ﹤0.01% 1203
2018
Q1 		$144 Hold
2
– – ﹤0.01% 1160
2017
Q4 		$208 Hold
2
– – ﹤0.01% 1169
2017
Q3 		$250 Hold
2
– – ﹤0.01% 1126
2017
Q2 		$197 Hold
2
– – ﹤0.01% 964
2017
Q1 		$330 Hold
2
– – ﹤0.01% 908
2016
Q4 		$450 Hold
2
– – ﹤0.01% 823
2016
Q3 		$660 Hold
2
– – ﹤0.01% 797
2016
Q2 		$578 Hold
2
– – ﹤0.01% 821
2016
Q1 		$1.26K Hold
2
– – ﹤0.01% 877
2015
Q4 		$2K Hold
2
– – ﹤0.01% 725
2015
Q3 		$2K Buy
+2
New +$2.05K ﹤0.01% 1004

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sonora Investment Management's RGLS Position: Q3 2021 in Review

Sonora Investment Management held its Regulus Therapeutics (RGLS) position steady in Q3 2021 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

Sonora Investment Management first reported a position in RGLS in Q3 2015 and has held it in 25 quarters since. The position peaked at $2K in Q4 2015. 41 funds tracked by Wall St. Rank hold RGLS as of Q3 2021.

  • Sonora Investment Management held 2 shares of Regulus Therapeutics worth $0 as of Q3 2021.
  • Sonora Investment Management left its Regulus Therapeutics share count unchanged in Q3 2021.
  • Regulus Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1109 holding.
  • Sonora Investment Management first reported a position in Regulus Therapeutics in Q3 2015 and has held it in 25 quarters since.
  • Sonora Investment Management's Regulus Therapeutics position peaked at $2K in Q4 2015.
  • 41 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.